- Assistant Professor of Clinical Psychology at the City College and Graduate Center, City University of New York
- Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
“Prospective data from 804 participants was used to determine associations between early cannabis use and later schizotypal symptoms… Cannabis use with onset prior to age 14 strongly predicted SPD [schizotypal personality disorder] symptoms in adulthood, independent of early adolescent SPD symptoms, major depression, anxiety disorder, other drug use, and cigarette use…
Our data provide further support for a strong association of early cannabis use with the development of symptoms characteristic of schizophrenia spectrum disorders. As with studies in schizophrenia, early SPD symptoms could not fully explain the association of early cannabis use with later schizotypal symptoms.”
“Early Cannabis Use and Schizotypal Personality Disorder Symptoms from Adolescence to Middle Adulthood,” Schizophrenia Research, May 2012
- Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
- Involvement and Affiliations:
- Assistant Professor of Clinical Psychology, City College and Graduate Center, City University of New York
- New York State licensed psychologist
- Associate Research Scientist, Department of Psychiatry, Columbia University, 2006-2008
- Postdoctoral research fellowship, Psychiatric Epidemiology, Columbia University, 2003-2006
- PhD, Clinical Psychology, Fordham University, 2003
- MA, Clinical Psychology, Fordham University, 2000
- BS, Human Development and Family Studies, Cornell University, 1998
- None found